The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lorazepam Macure 4 mg/ml solution for injection



Macure Pharma ApSPA23199/002/001

Main Information

Trade NameLorazepam Macure 4 mg/ml solution for injection
Active SubstancesLorazepam
Dosage FormSolution for injection
Licence HolderMacure Pharma ApS
Licence NumberPA23199/002/001

Group Information

ATC CodeN05BA06 lorazepam

Status

License statusAuthorised
Licence Issued26/11/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back